I-29 The natural history of infections caused by varicella-zoster virus (VZV): primary infection, transmission, latency, and reactivation.  by Gershon, M.D.
Concurrent Sessions S11
compared to that of HepG2 or SNU475 with the GA or AA
genotype.
Conclusions: Our ﬁndings suggested that the EGF 61AA
genotype may lower HCC risk compared with GG and GA
genotypes, and have lower level of EGF protein. In addition,
block EGF signaling transduction via geﬁtinib can slowdown
the proliferations of some HCC cell lines.
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Studies of live attenuated varicella vaccine (Oka strain)
have led to increased understanding of the behavior of this
virus in human populations. For example, it has become
clear that VZV spreads predominately from the skin lesions
of patients with varicella (chickenpox) or zoster (shingles),
which contain high concentrations of cell-free virions that
are highly transmissible to others by the airborne route. At
least 3 cellular receptors for VZV have been identiﬁed.
This presentation will focus on the importance of the
mannose 6-phosphate receptor (MPR) and its role in viral
entry and egress from cells. Because MPRs are lost during
the natural maturation of the superﬁcial epidermis, VZV-
infected maturing keratinocytes release infectious viral
particles into the epidermal vesicles that form during
varicella or zoster. In human infection, cellular immunity
is required for host defense against VZV because non-
epidermal cells express MPRs and thus do not release
infectious virions. VZV thus spreads from one cell to another
without entering the extracellular space. The exclusive
cell-to-cell spread of VZV in the body contributes to the
relatively long varicella incubation period, decreases the
viral load during disease (because much of the intracellular
virus is degraded in endosomes), and prevents the host
from being overwhelmed by VZV. In evolutionary terms, it
is an advantage for the virus not to overwhelm its host
and to establish a latent infection so that it can persist
after a varicella epidemic has exhausted the population of
susceptible hosts, and reactivate to spread again, after a
population of susceptible hosts is regenerated.
In an in vitro neuronal model of VZV infection, only cell-free
VZV establishes latent infection. Because the epidermis is
the only site in which infectious free virions emerge, this
observation suggests that skin infection is necessary for the
establishment of VZV latency. Infection of intraepidermal
sensory nerve terminals enables VZV to establish latency
in dorsal root and cranial nerve ganglia. During latency, a
limited number of VZV genes are transcribed. The same
genes are transcribed during latency in infected human
ganglia and in cultured intestinal neurons isolated from
either guinea pig or mouse. This neuronal model of VZV
infection is useful because lytic or latent infections can
be studied and VZV can be reactivated from latency. Both
wild-type VZV and the vaccine (Oka) strain can establish
latency and reactivate in neurons in vitro.
Basic studies on VZV have helped to promote understanding
of how varicella vaccine behaves in human hosts. This
knowledge, in turn, has contributed to recommendations
for vaccine use. For example, the risk of manifesting zoster
is low in vaccinees who lack a history of skin lesions from
either vaccine or wild type VZV. In addition, skin lesions with
infectious VZV are required for host-to-host transmission;
therefore, decreasing the number of skin lesions due to VZV
decreases VZV transmission. In order to maximize protection
of vaccinees from chickenpox and minimize skin lesions, two
doses of vaccine are now recommended for all children in
the United States.
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Antimicrobial agents is the most frequent prescribed
drug in China, near 40% of the drug consumption is
antimicrobial agents, 60 70% of hospitalized patients
receive antimicrobial agent therapy and 20 30% outpatient
prescriptions contain those agents. The top three
antimicrobials by the drug classiﬁcation are ﬂuoroquinolone,
cephalosporin and macrolide. The irrational antibiotic
application is a severe public health problem in China.
In community and hospital setting, antimicrobials
are used for the treatment of bacterial infection,
common cold and other un-infectives. The catalog of
antimicrobials irrational use reasons includes prescription
without indication, favoring intravenous administration,
unnecessary combination, longer duration, higher dosage
and others.
Except healthcare consumption, half of the antibiotic
output is used in animal breeding as growth promoter,
which is added in the animal feeding.
The reasons of irrational use are: healthcare system
ﬁnancial compensation defect, patient claim and pressure,
unmet physician education, STG unavailable and industrial
promotion.
The results of irrational use of antimicrobials are:
1. Severe bacterial resistance: 70% E. coli being
resistant to ﬂuoroquinolone, over 80% macrolide-
resistant Streptococcus and Staphylococcus being
detected, ESBLs(+) Enterobacteriaceae being 10 20%,
penicillin non-sensitive S. pneumoniae increasing
steadily, methicillin-resistant Staphylococcus being 60%
national-widely, etc.
2. Antibiotic-related ADR and drug sufferings: 50% ADR
report collected in national ADR center was antibiotic-
related, some national wide drug sufferings was reported
occasionally.
3. Wasting medicinal resource.
The measures ﬁghting against the antibiotic irrational use
should be:
1. Healthcare system reform, which is being on the way.
2. STG generating and enforcing; some hospitals or medical
associations are preparing their own STG.
3. Professional employees and patients education.
4. Legalization industrial promotion.
5. Restriction of animal use for growth promoter.
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Prenyltransferases are involved in many biological
pathways; thus they are useful for developing new drugs
for various diseases. We have studied by structural analysis
the product chain length determinants of several trans-type
prenyltransferases, including geranylgeranyl pyrophosphate
synthase (GGPPS) and so on. The speciﬁcities were
determined by the size and depth of the activity site
cavity. Large amino acids form the ﬂoor to block product
further elongation. In addition, we solved the structures
